Canakinumab
In the US, Canakinumab (canakinumab systemic) is a member of the drug class interleukin inhibitors and is used to treat Cryopyrin-Associated Periodic Syndromes, Familial Cold Autoinflammatory Syndrome and Muckle Wells Syndrome.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L04AC08
CAS registry number (Chemical Abstracts Service)
0914613-48-2
Chemical Formula
C6452-H9958-N1722-O2010-S42
Therapeutic Categories
Immunosuppressant
Monoclonal antibody
Chemical Name
Immunoglobulin G1, anti-[Homo sapiensinterleukin 1, beta (IL1B)] human monoclonal ACZ885; gamma1 heavy chain (Homo sapiensVH-IGHG1*03) (221-214)-disulfide with kappa light chain (Homo sapiensV-KAPPA-IGKC*01); (227-227:230-230 (WHO )
Foreign Names
- Canakinumabum (Latin)
- Canakinumab (German)
- Canakinumab (French)
- Canakinumab (Spanish)
Generic Names
- Canakinumab (OS: USAN, BAN)
- ACZ885 (IS)
- UNII-37CQ2C7X93 (IS)
Brand Names
- Ilaris
Novartis, Canada; Novartis, Switzerland; Novartis, Germany; Novartis, France; Novartis, United Kingdom; Novartis, Lithuania; Novartis, Norway; Novartis, Sweden; Novartis, United States; Novartis Europharm, Austria; Novartis Europharm Limited, Latvia; Novartis Farma, Italy; Novartis Farmaceutica, Spain; Novartis Healthcare, Philippines
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.


